It was found that TS could reduce the levels of Iba-1 and GFAP and the activation of microglia and astrocytes, thereby reducing the levels of TNF-α, IL-1β, IL-1, and the release of proinflammatory factors in APP/PS1 mice to inhibit neuroinflammation. Here, GFAP is linked to Timothy syndrome.